Michelle Skornicki, MS
Senior Research Scientist
Ms. Skornicki is an expert in biostatistics and infectious disease epidemiology. Ms. Skornicki has ten years of progressive experience in health services and outcomes research, health economics, and epidemiology. Her prior experience has included research positions at the Massachusetts Veterans Epidemiology Research and Information Center, i3 Innovus/OptumInsight, and Organogenesis, a producer of regenerative healing technologies. Ms. Skornicki has developed and published a number of economic models for infectious diseases including pertussis and HIV, as well as retrospective database analyses in epilepsy and chronic wounds.
MPH, Boston University School of Public Health
BA, Mathematics, Hamilton College
- McGarry LJ, et al. Cost-effectiveness of Tdap vaccination of adults aged ≥65 years in the prevention of pertussis in the US: a dynamic model of disease transmission. PloS One. 2014.
- Rice JB, et al. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2014.
- Skornicki M, et al. Budget impact analysis of antiepileptic drugs for Lennox-Gastaut syndrome. J Manag Care Spec Pharm. 2014.